Open AccessAdvances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis
Author(s) -
Bergmeier Wolfgang,
Antoniak Silvio,
Conway Edward M.,
Denis Cécile V.,
George Lindsey A.,
Isermann Berend,
Key Nigel S.,
Krishnaswamy Sriram,
Lam Wilbur A.,
Lillicrap David,
Liu Jian,
Looney Mark R.,
López José A.,
Maas Coen,
Peyvandi Flora,
Ruf Wolfram,
Sood Anil K.,
Versteeg Henri H.,
Wolberg Alisa S.,
Wong Pancras C.,
Wood Jeremy P.,
Weiler Hartmut
Publication year - 2018
Publication title -
research and practice in thrombosis and haemostasis
Language(s) - English
Resource type - Journals
ISSN - 2475-0379
DOI - 10.1002/rth2.12095
Subject(s) - chapel , medicine , hemostasis , tissue factor , library science , coagulation , surgery , art , art history , computer science
This 9th Symposium on Hemostasis is an international scientific meeting held biannually in Chapel Hill, North Carolina. The meeting is in large measure the result of the close friendship between the late Dr. Harold R. Roberts of UNC Chapel Hill and Dr. Ulla Hedner of Novo Nordisk. When Novo Nordisk was developing the hemophilia therapy that would become NovoSeven, they sponsored a series of meetings to understand the basic biology and clinical applications of factor VII a. The first meeting in Chapel Hill was held April 4‐6, 2002 with Dr. Roberts as the organizer. Over the years, the conference emphasis has expanded from discussions of factor VII a and tissue factor to additional topics in hemostasis and thrombosis. This year's meeting includes presentations by internationally renowned speakers that discuss the state‐of‐the‐art on an array of important topics, including von Willebrand factor, engineering advances, coagulation and disease, tissue factor biology, therapeutic advances, and basic clotting factor biology. Included in this review article are illustrated abstracts provided by our speakers, which highlight the main conclusions of each invited talk. This will be the first meeting without Dr. Roberts in attendance, yet his commitment to excellent science and his focus on turning science to patient care are pervasively reflected in the presentations by our speakers.